Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
Nicole de Buhr, T Baumann, Christopher Werlein, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12

Showing 12 citing articles:

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 27
Targeting Neutrophil Extracellular Traps for Stroke Prognosis: A Promising Path
Eirini Liaptsi, Ermis Merkouris, Efthymia Polatidou, et al.
Neurology International (2023) Vol. 15, Iss. 4, pp. 1212-1226
Open Access | Times Cited: 13
Potential mechanisms of vaccine-induced thrombosis
Marco Marietta, Valeria Coluccio, Mario Luppi
European Journal of Internal Medicine (2022) Vol. 105, pp. 1-7
Open Access | Times Cited: 21
Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia
Johannes Hirsch, Günalp Uzun, Jan Zlamal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies
Martin Heil
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination
Malika Aïd, Kathryn E. Stephenson, Ai‐ris Y. Collier, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia
Victoria Panagiota, Christiane Dobbelstein, Sonja Werwitzke, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1702-1702
Open Access | Times Cited: 12
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Neurological Manifestations of SARS-CoV-2 Infection and the Role of Complement Activation
Mustafa Jaffry, Iqra Faiz, Kazim Jaffry, et al.
touchREVIEWS in Neurology (2022) Vol. 18, Iss. 2, pp. 86-86
Open Access | Times Cited: 6
Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist device
Juliane Hupe, Hans Worthmann, Kim Kristin Ravenberg, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV‐19 vaccination and in normal unvaccinated blood donors
Magne K. Fagerhol, Nina Haagenrud Schultz, Mohammad Reza Mirlashari, et al.
Scandinavian Journal of Immunology (2023) Vol. 98, Iss. 1
Open Access | Times Cited: 1
AZD-1222

Reactions Weekly (2023) Vol. 1946, Iss. 1, pp. 104-104
Closed Access
Page 1

Scroll to top